provides funding for Anthropometric and Genetic Factors Associated with the Exposure of Rifampicin and Isoniazid in Mexican Patients with Tuberculosis Article Population pharmacokinetics of isoniazid and dose recommendations in Mexican patients with tuberculosis Article
